AMGN · Amgen Inc.
Is AMGN setting up for a breakout, what are traders on X and the news saying, are its insiders buying, and how is the business doing? Everything Raspberry Trades measures on Amgen Inc., in one place.
Today's breakout radarIs AMGN setting up for a breakout?
Breakout Radar API →AMGN reports earnings on Nov 3, 2026 — a breakout right before a report can reverse on the numbers.
Not today. AMGN is not on today's radar: no tight base just under a resistance that has been tested again and again.
See the stocks that are setting up today →What are traders on X saying about AMGN?
Stock Sentiment API →Bulls: Amgen's drug combo cut the risk of death from lung cancer by 58% (10/26/26), and dazodalibep met the primary endpoint in the Phase 3 OASIZ-301 Sjögren's syndrome trial — both dosing regimens significantly reduced systemic disease activity, and the every-four-week regimen also reduced patient-reported dryness. Technically, AMGN has built an ascending triangle all fall, stalling three times near $451 with every dip stopping at a higher low; a close above that flat top would be the textbook breakout.
Bears: Amgen received an FDA warning letter (dated Aug. 12) for Vectibix misbranding: an FDA-reviewed video touts "No premedication" beside a crossed-out IV bag while "entirely omits risk information," despite Vectibix carrying a boxed warning for dermatologic toxicity.
Reading from Oct 28, 2026; each post classified by AI, weighted by engagement.
What is the news saying about AMGN?
News Sentiment API →No recent news reading for AMGN. The News Sentiment API reads today's headlines on any US stock.
Are AMGN insiders buying or selling?
Insider Trading API →Open-market trades only, from SEC Form 4 filings — option exercises, tax withholding and grants are left out.
- Sold · Khosla Rachna$825K · Aug 11, 2026
- Sold · Grygiel Nancy A.$400K · May 4, 2026
- Sold · Busch Matthew C.$376K · Feb 19, 2026
- Sold · Grygiel Nancy A.$553K · Nov 20, 2025
- Sold · Grygiel Nancy A.$506K · Nov 20, 2025
How is Amgen Inc.'s business doing?
Financial Statements API →| Quarter ended | Revenue | vs year before | Net income | EPS |
|---|---|---|---|---|
| Jun 30, 2026 | $10.1B | +10% | $2.4B | $4.37 |
| Mar 31, 2026 | $8.6B | +6% | $1.8B | $3.34 |
| Sep 30, 2025 | $9.6B | +12% | $3.2B | $5.93 |
| Jun 30, 2025 | $9.2B | +9% | $1.4B | $2.65 |
From the company's SEC filings (10-Q and 10-K).
What does Amgen Inc. expect?
Company Guidance API →- full year 2026 · total revenues · 8-K filed Aug 4, 2026
“Total revenues in the range of $38.2 billion to $39.4 billion.”
- full year 2026 · eps · 8-K filed Aug 4, 2026
“On a GAAP basis, EPS in the range of $15.80 to $17.08, and a tax rate in the range of 14.5% to 16.0%.”
- full year 2026 · tax rate · 8-K filed Aug 4, 2026
“On a GAAP basis, EPS in the range of $15.80 to $17.08, and a tax rate in the range of 14.5% to 16.0%.”
- full year 2026 · eps · 8-K filed Aug 4, 2026
“On a non-GAAP basis, EPS in the range of $22.30 to $23.50, and a tax rate in the range of 15.0% to 16.5%.”
Quoted from the outlook the company filed with the SEC.
Free account, no card: today's top 5 with charts, by email before the open.
Measured data, not recommendations. Not investment advice.